Cargando…
Preclinical studies of toxicity and safety of the AS-48 bacteriocin
The in vitro antimicrobial potency of the bacteriocin AS-48 is well documented, but its clinical application requires investigation, as its toxicity could be different in in vitro (haemolytic and antibacterial activity in blood and cytotoxicity towards normal human cell lines) and in vivo (e.g. mice...
Autores principales: | Cebrián, Rubén, Rodríguez-Cabezas, M. Elena, Martín-Escolano, Rubén, Rubiño, Susana, Garrido-Barros, María, Montalbán-López, Manuel, Rosales, María José, Sánchez-Moreno, Manuel, Valdivia, Eva, Martínez-Bueno, Manuel, Marín, Clotilde, Gálvez, Julio, Maqueda, Mercedes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637140/ https://www.ncbi.nlm.nih.gov/pubmed/31360546 http://dx.doi.org/10.1016/j.jare.2019.06.003 |
Ejemplares similares
-
Insights into Chagas treatment based on the potential of bacteriocin AS-48
por: Martín-Escolano, Rubén, et al.
Publicado: (2019) -
Control of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme
por: Cebrián, Rubén, et al.
Publicado: (2018) -
Synergy of the Bacteriocin AS-48 and Antibiotics against Uropathogenic Enterococci
por: Montalbán-López, Manuel, et al.
Publicado: (2020) -
LAB Bacteriocins Controlling the Food Isolated (Drug-Resistant) Staphylococci
por: Perales-Adán, Jesús, et al.
Publicado: (2018) -
Advances in the preclinical characterization of the antimicrobial peptide AS-48
por: Cebrián, Rubén, et al.
Publicado: (2023)